Can immunotherapy cure leukemia?
VIDEOS
Genetically Modified T Cells Obliterate Chronic Lymphocytic Leukemia Tumors
August 31, 2011, Penn Medicine
Promising gene therapy treats Leukemia
August 11, 2011, CBSNewsOnline
'Amazing' Therapy Wipes Out Leukemia In Study
August 11, 2011, WTAE TV
Genetically Modified T Cells Obliterate Chronic Lymphocytic Leukemia Tumors
August 31, 2011, Penn Medicine
Promising gene therapy treats Leukemia
August 11, 2011, CBSNewsOnline
'Amazing' Therapy Wipes Out Leukemia In Study
August 11, 2011, WTAE TV
ARTICLES
93 percent of advanced leukemia patients in remission after immunotherapy
April 27, 2016, ScienceDaily
New Monoclonal Antibody Targets Intracellular Oncogenic Proteins in Leukemias
March 26, 2013, Cancer Network
Novartis Gets Immune-Cell Cancer Therapy in UPenn Pact
August 6, 2012, Bloomberg
Novartis, Penn to Partner on Cancer Immunotherapies
August 6, 2012, Science Business
Novartis and Penn Unite on New Anticancer Path
August 6, 2012, The New York Times
A phase I/II clinical trial of autologous cytokine-induced killer cells as adjuvant immunotherapy for acute and chronic myeloid leukemia in clinical remission.
August 2012, PublMed
New advances in leukaemia immunotherapy by the use of Chimeric Artificial Antigen Receptors (CARs): state of the art and perspectives for the near future
September 22, 2011, Italian Journal of Pediatrics
Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia
August 25, 2011, The New England Journal of Medicine
New leukemia treatment exceeds 'wildest expectations'
August 10, 2011, Today Health
Next-generation leukemia immunotherapy
June 21, 2011, Journal Blood
93 percent of advanced leukemia patients in remission after immunotherapy
April 27, 2016, ScienceDaily
New Monoclonal Antibody Targets Intracellular Oncogenic Proteins in Leukemias
March 26, 2013, Cancer Network
Novartis Gets Immune-Cell Cancer Therapy in UPenn Pact
August 6, 2012, Bloomberg
Novartis, Penn to Partner on Cancer Immunotherapies
August 6, 2012, Science Business
Novartis and Penn Unite on New Anticancer Path
August 6, 2012, The New York Times
A phase I/II clinical trial of autologous cytokine-induced killer cells as adjuvant immunotherapy for acute and chronic myeloid leukemia in clinical remission.
August 2012, PublMed
New advances in leukaemia immunotherapy by the use of Chimeric Artificial Antigen Receptors (CARs): state of the art and perspectives for the near future
September 22, 2011, Italian Journal of Pediatrics
Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia
August 25, 2011, The New England Journal of Medicine
New leukemia treatment exceeds 'wildest expectations'
August 10, 2011, Today Health
Next-generation leukemia immunotherapy
June 21, 2011, Journal Blood
